The invention provides pills for treating cervical spondylosis. The pills are characterized in that the drug effective component is prepared from the following raw material drugs in parts by weight: 20 to 50 parts of gastrodia elata, 20 to 40 parts of notopterygium root, 20 to 40 parts of radix angelicae pubescentis, 30 to 60 parts of red-rooted salvia root, 20 to 50 parts of white peony root, 20 to 40 parts of ground beetle dried body, 15 to 30 parts of angelica root, 10 to 30 parts of asarum, 10 to 30 parts of safflower, 10 to 30 parts of peach kernel, 10 to 30 parts of Chinese atractylode rhizome, 20 to 50 parts of hemlock parsley, 10 to 30 parts of kudzuvine root, 20 to 50 parts of wooly datchmanspipe herb, 20 to 50 parts of natural copper, 20 to 50 parts of garden balsam stem, 20 to 50 parts of simple leaf shrub chastetree fruit, 10 to 30 parts of tribulus terrestris L, 20 to 50 parts of fried date kernel, 20 to 50 parts of albizia flower, 20 to 50 parts of thinleaf milkwort root-bark, 20 to 50 parts of poria with hostwood, 10 to 30 parts of costustoot, 20 to 60 parts of amber, 20 to 50 parts of earthworm, 10 to 30 parts of leech, 10 to 30 parts of frankincense, 10 to 30 parts of myrrh, and 20 to 60 parts of cinnabar. The pills have the remarkable effects of expelling pathogenic cold and dispelling wind, soothing liver and relieving pains, relieving convulsion and soothing nerves, removing stasis, treating stranguria and relieving pains, and recovering joint function of the cervical spondylosis. Clinical practice proves that: the effective rate of the pills for treating cervical spondylosis is nearly 97 percent.